Selected article for: "antiviral type and ifn response"
Author: Duncan, Christopher J.A.; Randall, Richard E.; Hambleton, Sophie
Title: Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
  • Cord-id: 70zfj2vw
  • Document date: 2020_9_22
    • ID: 70zfj2vw
    Snippet: The concept that type I interferons (IFN-I) are essential to antiviral immunity derives from studies on animal models and cell lines. Virtually all pathogenic viruses have evolved countermeasures to IFN-I restriction, and genetic loss of viral IFN-I antagonists leads to virus attenuation. But just how important is IFN-I to antiviral defence in humans? The recent discovery of genetic defects of IFN-I signalling illuminates this and other questions of IFN biology, including the role of the mucosa-
    Document: The concept that type I interferons (IFN-I) are essential to antiviral immunity derives from studies on animal models and cell lines. Virtually all pathogenic viruses have evolved countermeasures to IFN-I restriction, and genetic loss of viral IFN-I antagonists leads to virus attenuation. But just how important is IFN-I to antiviral defence in humans? The recent discovery of genetic defects of IFN-I signalling illuminates this and other questions of IFN biology, including the role of the mucosa-restricted type III IFNs (IFN-III), informing our understanding of the place of the IFN system within the concerted antiviral response. Here we review monogenic lesions of IFN-I signalling pathways and summarise the organising principles which emerge.

    Search related documents:
    Co phrase search for related documents
    • activator signal transducer and acute infection: 1, 2, 3, 4, 5, 6
    • activator signal transducer and adaptive immunity: 1, 2
    • acute infection and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
    • acute infection and additional patient: 1, 2, 3
    • acute infection and live viral: 1, 2, 3
    • acute infection and low concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute infection and low patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute infection and low patient number: 1
    • adaptive immunity and live viral: 1, 2, 3, 4
    • adaptive immunity and low concentration: 1
    • adaptive immunity and low patient: 1, 2